Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy

NCT04480125 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Peripheral T-cell Lymphoma

Interventions

DRUG: Azacitidine
DRUG: Chidamide

Sponsor

Ruijin Hospital